Ever Source Wealth Advisors, LLC Amicus Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,194 shares of FOLD stock, worth $10,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,194
Previous 599
99.33%
Holding current value
$10,578
Previous $6,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$259 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$252 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$216 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$215 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$205 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.49B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...